 Lung Diseases
"Lung Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes involving any part of the LUNG.
| Descriptor ID |
D008171
|
| MeSH Number(s) |
C08.381
|
| Concept/Terms |
Lung Diseases- Lung Diseases
- Disease, Lung
- Diseases, Lung
- Lung Disease
- Pulmonary Disease
- Disease, Pulmonary
- Diseases, Pulmonary
- Pulmonary Diseases
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases".
- Lung Diseases
- Acute Chest Syndrome
- alpha 1-Antitrypsin Deficiency
- Cystic Adenomatoid Malformation of Lung, Congenital
- Cystic Fibrosis
- Hemoptysis
- Hepatopulmonary Syndrome
- Hypertension, Pulmonary
- Lung Abscess
- Lung Diseases, Fungal
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Lung Diseases, Parasitic
- Lung Injury
- Lung Neoplasms
- Lung, Hyperlucent
- Plasma Cell Granuloma, Pulmonary
- Pneumonia
- Pulmonary Alveolar Proteinosis
- Pulmonary Atelectasis
- Pulmonary Edema
- Pulmonary Embolism
- Pulmonary Eosinophilia
- Pulmonary Fibrosis
- Pulmonary Veno-Occlusive Disease
- Respiratory Distress Syndrome, Adult
- Respiratory Distress Syndrome, Newborn
- Scimitar Syndrome
- Solitary Pulmonary Nodule
- Tuberculosis, Pulmonary
This graph shows the total number of publications written about "Lung Diseases" by people in this website by year, and whether "Lung Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 | | 1997 | 5 | 4 | 9 | | 1998 | 5 | 0 | 5 | | 1999 | 3 | 2 | 5 | | 2000 | 4 | 2 | 6 | | 2001 | 10 | 1 | 11 | | 2002 | 8 | 1 | 9 | | 2003 | 8 | 1 | 9 | | 2004 | 16 | 1 | 17 | | 2005 | 7 | 2 | 9 | | 2006 | 14 | 3 | 17 | | 2007 | 18 | 3 | 21 | | 2008 | 16 | 3 | 19 | | 2009 | 6 | 6 | 12 | | 2010 | 12 | 4 | 16 | | 2011 | 16 | 6 | 22 | | 2012 | 17 | 4 | 21 | | 2013 | 20 | 2 | 22 | | 2014 | 20 | 0 | 20 | | 2015 | 21 | 5 | 26 | | 2016 | 21 | 3 | 24 | | 2017 | 21 | 3 | 24 | | 2018 | 32 | 7 | 39 | | 2019 | 20 | 1 | 21 | | 2020 | 17 | 1 | 18 | | 2021 | 17 | 1 | 18 | | 2022 | 16 | 0 | 16 | | 2023 | 19 | 1 | 20 | | 2024 | 5 | 8 | 13 | | 2025 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases" by people in Profiles.
-
Hua JT, Zell-Baran LM, Cool CD, Krefft SD, Go LHT, Cohen RA, Majka SM, Rose CS. Quantitative lung particulate analysis links increased anthracotic pigment burden to burn pit exposure in post-9/11 veterans with distal lung disease. Sci Rep. 2025 Dec 17; 15(1):43992.
-
Nasa P, Yurttas T, Battaglini D, Blot S, Fernandez-Bustamante A, Gama de Abreu M, van Meenen DM, Myatra SN, Serpa Neto A, Oppong R, Paulus F, Renukappa S, Schultz MJ, Slutsky AS, Hemmes SNT. Consensus on the definition, components, timeframe and grading of composite outcome of postoperative pulmonary complication-protocol for an international mixed-method consensus study (PrECiSIOn). BMJ Open. 2025 Aug 19; 15(8):e103888.
-
Lingappan K, Sundar IK, Prakash YS, Redente EF, Sin DD, Han MK, Lahm T, Krymskaya VP, Kotton DN, Kulkarni HS, Jain R, Königshoff M, Eghbali M, Anguera M, Arnold A, Silveyra P, DeMeo DL. Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2025 Aug; 211(8):1346-1368.
-
El-Merhie N, Staab-Weijnitz CA, Burgess JK, Kwapiszewska G. Beyond classical collagen: basement membrane collagen IV in age-associated lung diseases. Eur Respir Rev. 2025 Jul; 34(177).
-
Singh S, Gumbo T, Wang JY, Boorgula GD, Burke A, Huang HL, McShane PJ, Amaro-Galvez R, Gross JE, Aryal S, Heysell SK, Srivastava S. Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. J Infect Dis. 2025 Jul 11; 231(6):1521-1531.
-
Mohning MP, Krefft SD. Use of Spirometry in Pulmonary Function Evaluation. Clin Chest Med. 2025 Sep; 46(3):401-412.
-
Verma M, Can UI, Reinhardt RL. ILC2 Diversity, Location, and Function in Pulmonary Disease. Immunol Rev. 2025 Jul; 332(1):e70036.
-
Colquhoun DA, Fernandez-Bustamante A. Association of neuromuscular reversal drug with postoperative pulmonary complications in bronchoscopy: definitional challenges. Br J Anaesth. 2025 Jul; 135(1):17-20.
-
Morimoto K, Daley CL. Comprehensive Management Algorithm for Mycobacterium avium Complex Pulmonary Disease in the Real-World Setting. Ann Am Thorac Soc. 2025 May; 22(5):651-659.
-
Mora Massad K, Dai Z, Petrache I, Ventetuolo CE, Lahm T. Lung endothelial cell heterogeneity in health and pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol. 2025 Jun 01; 328(6):L877-L884.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|